Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
08 Jun 2018  |  North America  |  Market Research
US Cardiac Troponin Diagnostics Market, Forecast to 2021
High Prevalence of Heart Disease Propels Market Growth
Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 May 2018  |  Europe  |  Market Research
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment
Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...
$3,000.00
Special Price $2,250.00 save 25 %
-
16 Apr 2018  |  Asia Pacific  |  Market Research
Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021
Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market
Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...
$3,000.00
Special Price $2,250.00 save 25 %
-
21 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Oncology Diagnostics Market, 2017
Surge in Adoption of Next Generation Sequencing (NGS) Solutions for Predictive Diagnosis Transforms the IVD Testing Landscape
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00
Special Price $1,125.00 save 25 %
-
21 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Growth Spurred by Simple and Accurate Point of Care (POC) Testing at Home for Urological Conditions such as Nephrolithiasis and Urinary Tract Infections (UTIs)
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00
Special Price $1,125.00 save 25 %
-
20 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Cardiology Diagnostics Market, 2017
Integrated Devices and User-friendly Cardiac Monitoring Products Focused on Home Care Offer New Growth Opportunities
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00
Special Price $1,125.00 save 25 %
-
18 Dec 2017  |  Global  |  Market Research
Strategic Insight into the Global Women’s Reproductive Health Diagnostics Market, 2017
Non-Invasive Prenatal Testing and Carrier Screening are the Key Segments Triggering Growth Across the Market
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00
Special Price $1,125.00 save 25 %
-
30 Nov 2017  |  Europe  |  Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
Special Price $2,250.00 save 25 %
-
25 Sep 2017  |  North America  |  Market Research
2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies
A Voice of Customer Study to Compare Trends Between Current and Potential Adopters of Digital Pathology Platforms
A digital pathology end-user research was conducted to identify trends and developments in the field of digital pathology. The survey sought to collect the key information on usage and adoption and compare the perceptions of current and potential adopters of this technology. For the survey, lab managers and pathologists of pathology facilities we...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Jul 2017  |  North America  |  Market Research
Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market
Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to u...
$4,950.00
Special Price $3,712.50 save 25 %